These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18837790)

  • 61. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).
    Pang T; Cardosa MJ; Guzman MG
    Immunol Cell Biol; 2007 Jan; 85(1):43-5. PubMed ID: 17130899
    [TBL] [Abstract][Full Text] [Related]  

  • 62. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?
    Mongkolsapaya J; Duangchinda T; Dejnirattisai W; Vasanawathana S; Avirutnan P; Jairungsri A; Khemnu N; Tangthawornchaikul N; Chotiyarnwong P; Sae-Jang K; Koch M; Jones Y; McMichael A; Xu X; Malasit P; Screaton G
    J Immunol; 2006 Mar; 176(6):3821-9. PubMed ID: 16517753
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever.
    Simmons CP; Popper S; Dolocek C; Chau TN; Griffiths M; Dung NT; Long TH; Hoang DM; Chau NV; Thao le TT; Hien TT; Relman DA; Farrar J
    J Infect Dis; 2007 Apr; 195(8):1097-107. PubMed ID: 17357045
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Augmented miR-150 expression associated with depressed SOCS1 expression involved in dengue haemorrhagic fever.
    Chen RF; Yang KD; Lee IK; Liu JW; Huang CH; Lin CY; Chen YH; Chen CL; Wang L
    J Infect; 2014 Oct; 69(4):366-74. PubMed ID: 24907421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Primary dengue haemorrhagic fever in patients from northeast of Brazil is associated with high levels of interferon-β during acute phase.
    Oliveira RA; Silva MM; Calzavara-Silva CE; Silva AM; Cordeiro MT; Moura PM; Baptista PN; Marques ET; Gil LH
    Mem Inst Oswaldo Cruz; 2016 May; 111(6):378-84. PubMed ID: 27223651
    [TBL] [Abstract][Full Text] [Related]  

  • 66. T-cell immunity to infection with dengue virus in humans.
    Weiskopf D; Sette A
    Front Immunol; 2014; 5():93. PubMed ID: 24639680
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF.
    Duangchinda T; Dejnirattisai W; Vasanawathana S; Limpitikul W; Tangthawornchaikul N; Malasit P; Mongkolsapaya J; Screaton G
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16922-7. PubMed ID: 20837518
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants.
    Adimy M; Mancera PFA; Rodrigues DS; Santos FLP; Ferreira CP
    Bull Math Biol; 2020 Jan; 82(2):24. PubMed ID: 31993759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytotoxic factor-autoantibodies: possible role in the pathogenesis of dengue haemorrhagic fever.
    Chaturvedi UC; Elbishbishi EA; Agarwal R; Mustafa AS
    FEMS Immunol Med Microbiol; 2001 Apr; 30(3):181-6. PubMed ID: 11335136
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MIP-1 alpha and MIP-1 beta induction by dengue virus.
    Spain-Santana TA; Marglin S; Ennis FA; Rothman AL
    J Med Virol; 2001 Oct; 65(2):324-30. PubMed ID: 11536240
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dengue Hemorrhagic Fever at 60 Years: Early Evolution of Concepts of Causation and Treatment.
    Halstead SB; Cohen SN
    Microbiol Mol Biol Rev; 2015 Sep; 79(3):281-91. PubMed ID: 26085471
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular classification of outcomes from dengue virus -3 infections.
    Brasier AR; Zhao Y; Wiktorowicz JE; Spratt HM; Nascimento EJ; Cordeiro MT; Soman KV; Ju H; Recinos A; Stafford S; Wu Z; Marques ET; Vasilakis N
    J Clin Virol; 2015 Mar; 64():97-106. PubMed ID: 25728087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dengue virus evolution and virulence models.
    Rico-Hesse R
    Clin Infect Dis; 2007 Jun; 44(11):1462-6. PubMed ID: 17479944
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endothelial cells in dengue hemorrhagic fever.
    Srikiatkhachorn A; Kelley JF
    Antiviral Res; 2014 Sep; 109():160-70. PubMed ID: 25025934
    [TBL] [Abstract][Full Text] [Related]  

  • 75. T-cell responses to dengue virus in humans.
    Kurane I; Matsutani T; Suzuki R; Takasaki T; Kalayanarooj S; Green S; Rothman AL; Ennis FA
    Trop Med Health; 2011 Dec; 39(4 Suppl):45-51. PubMed ID: 22500136
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dengue conundrums.
    Gibbons RV
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S36-9. PubMed ID: 20696556
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Understanding the Human T Cell Response to Dengue Virus.
    Rivino L
    Adv Exp Med Biol; 2018; 1062():241-250. PubMed ID: 29845537
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome.
    Kurane I; Rothman AL; Livingston PG; Green S; Gagnon SJ; Janus J; Innis BL; Nimmannitya S; Nisalak A; Ennis FA
    Arch Virol Suppl; 1994; 9():59-64. PubMed ID: 8032282
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dengue haemorrhagic fever: a job done via exosomes?
    Mishra R; Lata S; Ali A; Banerjea AC
    Emerg Microbes Infect; 2019; 8(1):1626-1635. PubMed ID: 31711408
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of mitogen-activated protein kinase signaling in the pathogenesis of dengue virus infection.
    Sreekanth GP; Yenchitsomanus PT; Limjindaporn T
    Cell Signal; 2018 Aug; 48():64-68. PubMed ID: 29753850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.